Leading Voices in Cell and Gene Therapy: Introducing Our Featured Speakers

We're excited to introduce speakers for the upcoming Advanced Therapies: Cell & Gene, mRNA and Beyond, a complimentary virtual event taking place on November 20, 2024. 

We’ll explore the latest insights, innovations, and challenges in cell and gene therapies and other advanced treatments. Leading experts from the FDA, Cellares, Mirai Bio, Adaptimmune, McKesson and more will examine the most pressing issues tied to advanced therapies, including safety, manufacturing, infrastructure and payer concerns, and cost-effectiveness.

Register today to secure your spot at this complimentary virtual event.

Arturo Araya
Cellares
Executive Vice President, Commercialization

Joe DePinto
McKesson
Head of Cell, Gene, and Advanced Therapies

Alexandria Forbes, Ph.D.
MeiraGTx
President and Chief Executive Officer

Steve Gavel
Legend Biotech
Senior Vice President, Cell Therapy Commercial Development

Peter Marks, M.D., Ph.D.
Food and Drug Administration
Director of the Center for Biologics Evaluation and Research (CBER)

Miloš Miljković, M.D.
Cartesian Therapeutics
Chief Medical Officer

Alina Monakhova
Adaptimmune
Vice President, Global Supply Chain

Hari Pujar, Ph.D.
Mirai Bio
President

• Cell & Gene Therapy Manufacturing: A Look at Supply Chains, Treatment Centers and Patient Slots
• Accelerating Genetic Medicines: Innovations in Biomanufacturing for Cell and Gene Therapy
• Cell & Gene Therapy Pulse Check: Overcoming Infrastructure and Payer Concerns
• Fireside Chat: What’s Beyond Cell & Gene Therapies 

If you no longer wish to receive promotion on this event, simply unsubscribe.
Refer to our Privacy Policy.

Fierce Life Sciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017

Contact Us
© 2024 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission.